Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huaiqi huang Granules plus dexamethasone vs dexamethasone in adult primary immune thrombocytopenia
ChiCTR2100042610Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Dalian Medical University
- Start
- Dec 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in immune thrombocytopenia (ITP) comparing Huaiqi huang Granules + dexamethasone with Dexamethasone (2 arms). Primary endpoints: Blood routine and Lymphocyte subsets. Started Dec 2020; status: recruiting.
02
Drugs
Huaiqihuangdexamethasone
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on ChiCTR2100042610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042610.